The cell biology of multiple drug resistance.

Suppr

超能文献

作者信息

Beck W T

出版信息

Biochem Pharmacol. 1987 Sep 15;36(18):2879-87. doi: 10.1016/0006-2952(87)90198-5.

DOI:10.1016/0006-2952(87)90198-5

PMID:2888464

Abstract

摘要

相似文献

The cell biology of multiple drug resistance.

Biochem Pharmacol. 1987 Sep 15;36(18):2879-87. doi: 10.1016/0006-2952(87)90198-5.

Multidrug resistance: molecular biology and clinical relevance.

J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.

Modulators of P-glycoprotein-associated multidrug resistance.

Cancer Treat Res. 1991;57:151-70. doi: 10.1007/978-1-4615-3872-1_7.

Multidrug resistance in cancer.

BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148.

The clinical relevance of multidrug resistance.

Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.

Studies on low-level MDR cells.

Cytotechnology. 1993;12(1-3):257-64. doi: 10.1007/BF00744667.

Mechanism of multidrug resistance.

Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.

Antineoplastic drug resistance and breast cancer.

Ann N Y Acad Sci. 1993 Nov 30;698:289-312. doi: 10.1111/j.1749-6632.1993.tb17220.x.

Laboratory aspects of multidrug resistance.

Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3.

Clinical implications of multidrug resistance to chemotherapy.

Cancer Treat Res. 1991;57:171-86. doi: 10.1007/978-1-4615-3872-1_8.

引用本文的文献

Aquaporins in colorectal cancer: exploring their role in tumorigenesis, metastasis, and drug response.

Hum Cell. 2024 Jul;37(4):917-930. doi: 10.1007/s13577-024-01078-7. Epub 2024 May 29.

The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy.

Front Immunol. 2023 Apr 28;14:1170754. doi: 10.3389/fimmu.2023.1170754. eCollection 2023.

Interactions of Environmental Chemicals and Natural Products With ABC and SLC Transporters in the Digestive System of Aquatic Organisms.

Front Physiol. 2022 Jan 13;12:767766. doi: 10.3389/fphys.2021.767766. eCollection 2021.

Deciphering the structure, function, expression and regulation of aquaporin-5 in cancer evolution.

Oncol Lett. 2021 Apr;21(4):309. doi: 10.3892/ol.2021.12571. Epub 2021 Feb 21.

New system to predict chemotherapeutic efficacy of drug combinations in fresh tumor samples.

PeerJ. 2017 Mar 2;5:e3030. doi: 10.7717/peerj.3030. eCollection 2017.

Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth.

Oncotarget. 2016 Jul 26;7(30):47479-47493. doi: 10.18632/oncotarget.10201.

Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance.

Iran J Basic Med Sci. 2016 Mar;19(3):300-9.

Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.

Cancer Gene Ther. 2014 Dec;21(12):526-31. doi: 10.1038/cgt.2014.59. Epub 2014 Nov 28.

AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.

Tumour Biol. 2014 Jul;35(7):7035-45. doi: 10.1007/s13277-014-1956-3. Epub 2014 Apr 23.

Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent.

PLoS One. 2012;7(8):e42293. doi: 10.1371/journal.pone.0042293. Epub 2012 Aug 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The cell biology of multiple drug resistance.

Biochem Pharmacol. 1987 Sep 15;36(18):2879-87. doi: 10.1016/0006-2952(87)90198-5.

Multidrug resistance: molecular biology and clinical relevance.

J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.

Modulators of P-glycoprotein-associated multidrug resistance.

Cancer Treat Res. 1991;57:151-70. doi: 10.1007/978-1-4615-3872-1_7.

Multidrug resistance in cancer.

BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148.

The clinical relevance of multidrug resistance.

Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.

Studies on low-level MDR cells.

Cytotechnology. 1993;12(1-3):257-64. doi: 10.1007/BF00744667.

Mechanism of multidrug resistance.

Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.

Antineoplastic drug resistance and breast cancer.

Ann N Y Acad Sci. 1993 Nov 30;698:289-312. doi: 10.1111/j.1749-6632.1993.tb17220.x.

Laboratory aspects of multidrug resistance.

Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3.

Clinical implications of multidrug resistance to chemotherapy.

Cancer Treat Res. 1991;57:171-86. doi: 10.1007/978-1-4615-3872-1_8.

引用本文的文献

Aquaporins in colorectal cancer: exploring their role in tumorigenesis, metastasis, and drug response.

Hum Cell. 2024 Jul;37(4):917-930. doi: 10.1007/s13577-024-01078-7. Epub 2024 May 29.

The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy.

Front Immunol. 2023 Apr 28;14:1170754. doi: 10.3389/fimmu.2023.1170754. eCollection 2023.

Interactions of Environmental Chemicals and Natural Products With ABC and SLC Transporters in the Digestive System of Aquatic Organisms.

Front Physiol. 2022 Jan 13;12:767766. doi: 10.3389/fphys.2021.767766. eCollection 2021.

Deciphering the structure, function, expression and regulation of aquaporin-5 in cancer evolution.

Oncol Lett. 2021 Apr;21(4):309. doi: 10.3892/ol.2021.12571. Epub 2021 Feb 21.

New system to predict chemotherapeutic efficacy of drug combinations in fresh tumor samples.

PeerJ. 2017 Mar 2;5:e3030. doi: 10.7717/peerj.3030. eCollection 2017.

Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth.

Oncotarget. 2016 Jul 26;7(30):47479-47493. doi: 10.18632/oncotarget.10201.

Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance.

Iran J Basic Med Sci. 2016 Mar;19(3):300-9.

Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.

Cancer Gene Ther. 2014 Dec;21(12):526-31. doi: 10.1038/cgt.2014.59. Epub 2014 Nov 28.

AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.

Tumour Biol. 2014 Jul;35(7):7035-45. doi: 10.1007/s13277-014-1956-3. Epub 2014 Apr 23.

Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent.

PLoS One. 2012;7(8):e42293. doi: 10.1371/journal.pone.0042293. Epub 2012 Aug 2.